-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
BridgeBio Pharma, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2024.
- BridgeBio Pharma, Inc. Operating Margin for the quarter ending September 30, 2024 was -250 %, a 95.8% increase year-over-year.
- BridgeBio Pharma, Inc. annual Operating Margin for 2023 was -6.53K %, a 890% decline from 2022.
- BridgeBio Pharma, Inc. annual Operating Margin for 2022 was -660 %, a 20.2% increase from 2021.
- BridgeBio Pharma, Inc. annual Operating Margin for 2021 was -827 %, a 85.6% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)